Xoma | XOMA - Trade Debtors


Xoma reported $14.78M in Trade Debtors for its fiscal quarter ending in June of 2024.





Trade Debtors Change Date
AbbVie USD 12.59B 180M Dec/2025
Agenus USD 22.44M 1.14M Dec/2025
Agios Pharmaceuticals USD 16.13M 5.56M Mar/2026
Ardelyx USD 71.85M 4.76M Dec/2025
aTyr Pharma USD 296.74M 295.7M Dec/2025
BioMarin Pharmaceutical USD 903.91M 4.3M Mar/2026
Celldex Therapeutics USD 230K 1.78M Mar/2026
Curis USD 2.55M 400K Jun/2024
Eli Lilly USD 21.18B 1.02B Mar/2026
Emergent BioSolutions USD 290.1M 134.2M Jun/2023
Incyte USD 1.05B 27.09M Mar/2026
MacroGenics USD 13.37M 55.86M Dec/2025
Novartis USD 9.6B 2.69B Mar/2026
Novartis USD 12.29B 3.3B Dec/2025
Pfizer USD 16.17B 332M Mar/2026
Prothena USD 5.16M 0 Dec/2023
Regeneron Pharmaceuticals USD 5.73B 10.1M Mar/2026
Xoma USD 14.78M 4.96M Jun/2024